167 related articles for article (PubMed ID: 12866047)
21. Single cyclic nucleotide-gated channels locked in different ligand-bound states.
Ruiz ML; Karpen JW
Nature; 1997 Sep; 389(6649):389-92. PubMed ID: 9311781
[TBL] [Abstract][Full Text] [Related]
22. Single-channel kinetics of the rat olfactory cyclic nucleotide-gated channel expressed in Xenopus oocytes.
Li J; Lester HA
Mol Pharmacol; 1999 May; 55(5):883-93. PubMed ID: 10220567
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of modulation by internal protons of cyclic nucleotide-gated channels cloned from sensory receptor cells.
Gavazzo P; Picco C; Menini A
Proc Biol Sci; 1997 Aug; 264(1385):1157-65. PubMed ID: 9308192
[TBL] [Abstract][Full Text] [Related]
24. Altered ligand specificity by protonation in the ligand binding domain of cyclic nucleotide-gated channels.
Gordon SE; Oakley JC; Varnum MD; Zagotta WN
Biochemistry; 1996 Apr; 35(13):3994-4001. PubMed ID: 8672432
[TBL] [Abstract][Full Text] [Related]
25. Control of ligand specificity in cyclic nucleotide-gated channels from rod photoreceptors and olfactory epithelium.
Altenhofen W; Ludwig J; Eismann E; Kraus W; Bönigk W; Kaupp UB
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9868-72. PubMed ID: 1719541
[TBL] [Abstract][Full Text] [Related]
26. Interaction between prostaglandin E2 and l-cis-diltiazem, a specific blocker of cyclic nucleotide gated channels in bovine aortic endothelial cells.
Shalom R; Barki-Harrington L; Rimon G
Eur J Pharmacol; 2006 Aug; 543(1-3):8-13. PubMed ID: 16842773
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of allosteric modulation of rod cyclic nucleotide-gated channels.
Sunderman ER; Zagotta WN
J Gen Physiol; 1999 May; 113(5):601-20. PubMed ID: 10228178
[TBL] [Abstract][Full Text] [Related]
28. Distinct structural determinants of efficacy and sensitivity in the ligand-binding domain of cyclic nucleotide-gated channels.
Young EC; Krougliak N
J Biol Chem; 2004 Jan; 279(5):3553-62. PubMed ID: 14594805
[TBL] [Abstract][Full Text] [Related]
29. Probing the interactions between cAMP and cGMP in cyclic nucleotide-gated channels using covalently tethered ligands.
He Y; Karpen JW
Biochemistry; 2001 Jan; 40(1):286-95. PubMed ID: 11141082
[TBL] [Abstract][Full Text] [Related]
30. Assembly of retinal rod or cone Na(+)/Ca(2+)-K(+) exchanger oligomers with cGMP-gated channel subunits as probed with heterologously expressed cDNAs.
Kang K; Bauer PJ; Kinjo TG; Szerencsei RT; Bönigk W; Winkfein RJ; Schnetkamp PP
Biochemistry; 2003 Apr; 42(15):4593-600. PubMed ID: 12693957
[TBL] [Abstract][Full Text] [Related]
31. A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa.
Paquet-Durand F; Beck S; Michalakis S; Goldmann T; Huber G; Mühlfriedel R; Trifunović D; Fischer MD; Fahl E; Duetsch G; Becirovic E; Wolfrum U; van Veen T; Biel M; Tanimoto N; Seeliger MW
Hum Mol Genet; 2011 Mar; 20(5):941-7. PubMed ID: 21149284
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism for ligand discrimination of cyclic nucleotide-gated channels.
Varnum MD; Black KD; Zagotta WN
Neuron; 1995 Sep; 15(3):619-25. PubMed ID: 7546741
[TBL] [Abstract][Full Text] [Related]
33. Sequence of events underlying the allosteric transition of rod cyclic nucleotide-gated channels.
Sunderman ER; Zagotta WN
J Gen Physiol; 1999 May; 113(5):621-40. PubMed ID: 10228179
[TBL] [Abstract][Full Text] [Related]
34. Gating of heteromeric retinal rod channels by cyclic AMP: role of the C-terminal and pore domains.
Bennett N; Ildefonse M; Pagès F; Ragno M
Biophys J; 2002 Aug; 83(2):920-31. PubMed ID: 12124274
[TBL] [Abstract][Full Text] [Related]
35. Ligand binding and activation in a prokaryotic cyclic nucleotide-modulated channel.
Nimigean CM; Pagel MD
J Mol Biol; 2007 Aug; 371(5):1325-37. PubMed ID: 17619023
[TBL] [Abstract][Full Text] [Related]
36. Molecular interactions of 3',5'-cyclic purine analogues with the binding site of retinal rod ion channels.
Scott SP; Tanaka JC
Biochemistry; 1995 Feb; 34(7):2338-47. PubMed ID: 7532007
[TBL] [Abstract][Full Text] [Related]
37. RIalpha subunit of PKA: a cAMP-free structure reveals a hydrophobic capping mechanism for docking cAMP into site B.
Wu J; Brown S; Xuong NH; Taylor SS
Structure; 2004 Jun; 12(6):1057-65. PubMed ID: 15274925
[TBL] [Abstract][Full Text] [Related]
38. Transmembrane S1 mutations in CNGA3 from achromatopsia 2 patients cause loss of function and impaired cellular trafficking of the cone CNG channel.
Patel KA; Bartoli KM; Fandino RA; Ngatchou AN; Woch G; Carey J; Tanaka JC
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2282-90. PubMed ID: 15980212
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of ligand activation in a cyclic nucleotide regulated potassium channel.
Clayton GM; Silverman WR; Heginbotham L; Morais-Cabral JH
Cell; 2004 Nov; 119(5):615-27. PubMed ID: 15550244
[TBL] [Abstract][Full Text] [Related]
40. Capturing cyclic nucleotides in action: snapshots from crystallographic studies.
Rehmann H; Wittinghofer A; Bos JL
Nat Rev Mol Cell Biol; 2007 Jan; 8(1):63-73. PubMed ID: 17183361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
